Optometrists in Pleasanton, TX Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Atascosa Vision Source,pa Optometrist Medicare: Medicare Enrolled Practice Location: 1514 W Oaklawn Rd, Pleasanton, TX 78064 Phone: 830-569-8771 Fax: 830-569-2346 |
 Dr. Christopher Mark Prough, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1514 W Oaklawn Rd, Pleasanton, TX 78064 Phone: 830-569-8771 Fax: 830-569-2346 |
Stephen P Planchet, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1514 W Oaklawn Rd, Pleasanton, TX 78064 Phone: 830-569-8771 Fax: 830-569-2346 |
Dr. Ron Dwaine Mixon, O.D. Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 2151 W Oaklawn Rd, Pleasanton, TX 78064 Phone: 830-569-3334 Fax: 830-281-3926 |
News Archive
Rigosertib drug shows promise against advanced pancreatic cancer
The American Cancer Society estimates that 44,000 new cases of pancreatic cancer will be diagnosed this year and that 37,000 people will die from the disease. These are not strong odds. A new drug, rigosertib, allows pancreatic cancer cells to rush through replication - and then stops them cold, killing them in in the middle of a step called M phase. Healthy cells that don't rush are unharmed.
Viralytics enters into clinical trial collaboration agreement with MSD
Viralytics Limited announced today that it has entered into a clinical trial collaboration agreement through subsidiaries of Merck & Co., Inc., Kenilworth, New Jersey, U.S.A. (known as MSD outside the United States and Canada) to evaluate the combination of Viralytics' investigational cancer immunotherapy CAVATAK, with MSD's KEYTRUDA, an anti-PD-1 (programmed death receptor-1) therapy.
Scientists develop new optical technique to observe neurotransmitter activity of individual synapses
Columbia University scientists have developed a new optical technique to study how information is transmitted in the brains of mice. Using this method, they found that only a small portion of synapses - the connections between cells that control brain activity-may be active at any given time.
CTD seeks small molecule drug discovery and therapeutic antibody targets from academic researchers
A major centre created by the Medical Research Council (MRC) and MRC Technology (MRCT) in order to fast-track the discovery and development of novel drugs, opens its first call for targets today.
Researchers discover ‘brake' that interferes with HIV's development into infectious agent
Viewed with a microscope, the virus faintly resembles a pineapple-the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.
› Verified 8 days ago
Speech-Language Pathologists
Optometrists
Occupational Therapists
Chiropractors
Podiatrists
Physical Therapists